| Revenue growth | 22.5% YoY in Q2 FY27; 12.2% in constant currency. |
|---|---|
| Margins | Adj. EBITDA margin improved to 26.3% in Q2. |
| Order book | $40.2M ACV from 31 existing and 1 new client. |
| Demand visibility | Won $40.2M ACV in Q2; traction in mid-market clients. |
| Management confidence | Strong momentum cited in AI and larger deal wins. |
Growth
Q2 FY27 revenue grew 22.5% YoY to ₹20,321M; adjusted PAT rose 8.1% YoY to ₹3,254M.
Outlook
Acquisition of Chirok Health to accelerate Provider segment growth; interim dividend of ₹0.15 declared; debt to be fully repaid in FY27.
Risks
Seasonal revenue fluctuations noted for Q3/Q4; voluntary attrition remains relatively high at 25.7%.
Last quarter's promises, checked
Delivered
- Full debt repayment in FY27 → On track per Q2 update (= BEAT)
- Adj. EBITDA margin 24-25% → delivered 26.3% (= BEAT)
- Seasonal revenue recurring in Q3/Q4 → Confirmed in current commentary (= BEAT)
Partly delivered
- Low double-digit organic growth → delivered 12.2% CC (Lower end of guide) (= PARTIAL)
Investor Presentation filed with BSE, NSE: SAGILITY. Summary written with AI assistance from the document.
Sagility Ltd: key numbers
- Share price
- ₹45.29
- Market cap
- ₹21,202 Cr
- Revenue (annual)
- ₹7,193 Cr
- Net profit (annual)
- ₹924.8 Cr
- P/E (TTM)
- 20.7×Sector 52.0×
- Promoter holding
- 50.95%+0.00% QoQ
- FII holding
- 10.38%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sagility Ltd
All →Sagility Dividend
Sagility Limited declared an interim dividend of ₹0.15 per equity share for the financial year 2026-27. The record date is set for October 30, 2026.
Sagility Results Update
Sagility Ltd reported Q2 FY27 revenue of ₹2,032.1 Crore, up 22.5% YoY. The company also declared an interim dividend of ₹0.15 per share.
Sagility Q2 FY27 Results: Net Profit ₹284.2 Cr, Up 13.3% YoY
Sagility Ltd reported revenue from operations of ₹2,032 Cr (+22.5% YoY) and net profit of ₹284.2 Cr (+13.3% YoY) for Q2 FY27.
- Key figure
- Net profit ₹284.2 Cr · +13.3% YoY
Sagility Acquisition Worth ₹304.1 Cr
Sagility's US subsidiary is acquiring Chirok Health LLC for up to US$ 32.35 million. This 100% stake acquisition strengthens Sagility's provider segment capabilities.
- Value
- ₹304.1 Cr
Sagility Board Meeting Date
Sagility Ltd disclosed its Board is scheduled for 22 Oct 2026 to consider Q1/H1 FY27 results and any interim dividend. No decision has been taken yet.
Sagility Other Announcement
Sagility Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, disclosing promoter holdings and ongoing indirect encumbrances.